Evelyn Grau
About Evelyn Grau
Evelyn Grau serves as the Vice President and Head of Product and Strategy for Oncology and Infectious Disease at Opentrons Labworks Inc., where she focuses on market positioning and product development. She has a strong background in marketing and product management, with experience in developing innovative diagnostic tools and personalized therapies.
Work at Opentrons
Evelyn Grau serves as the Vice President, Head of Product and Strategy for Oncology and Infectious Disease at Opentrons Labworks Inc. since 2022. In this role, she is responsible for developing market positioning, pricing strategies, and conducting business case analyses for oncology and infectious disease products. Grau utilizes customer segmentation and digital marketing strategies to enhance product visibility and adoption. Her work focuses on setting strategy and product design for infectious disease PCR diagnostics, informed by market data and insights from key opinion leaders and healthcare stakeholders.
Education and Expertise
Evelyn Grau has a diverse educational background. She studied at the University of Buffalo, earning a Bachelor's degree in Accounting and Finance. She furthered her education at the University of Pennsylvania - The Wharton School, where she achieved an MBA with a focus on Marketing. Additionally, she attended the New York State Center of Excellence, specializing in Advanced Biomedical & Bioengineering Technology and obtaining a Leadership in Life Sciences certification. This combination of education equips her with a strong foundation in both business and scientific disciplines.
Background
Evelyn Grau has extensive experience in product management and marketing across various organizations. Before joining Opentrons, she held several key positions, including Senior Director of Product Management and Marketing at Adaptive Biotechnologies Corp. from 2021 to 2022, and Vice President of Marketing at NMS Labs from 2019 to 2021. Her earlier roles include Senior Product Marketing Manager at Lactalis American Group and Global Brand Manager at Life Technologies. Grau's career spans over two decades, with a focus on oncology and infectious disease products.
Achievements
Evelyn Grau has led significant projects in the field of oncology diagnostics. She was instrumental in the development and commercialization of the novel NGS 607 gene tumor-blood DNA profile, which detects mutations across 16 different cancers. Additionally, she developed the NGS RNA Fusion panel of 86 genes, aimed at matching patients with personalized therapies and clinical trials. Her contributions have advanced product strategies and enhanced the visibility of oncology and infectious disease products in the market.